P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes
Open Access
- 16 July 2018
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 128 (8), 3490-3503
- https://doi.org/10.1172/jci94524
Abstract
Purinergic receptor-7 (P2X7R) signaling controls Th17 and Th1 generation/differentiation, while NOD-like receptor P3 (NLRP3) acts as a Th2 transcriptional factor. Here, we demonstrated the existence of a P2X7R/NLRP3 pathway in T cells that is dysregulated by a P2X7R intracellular region loss-of-function mutation, leading to NLRP3 displacement and to excessive Th17 generation due to abrogation of the NLRP3-mediated Th2 program. This ultimately resulted in poor outcomes in cardiac-transplanted patients carrying the mutant allele, who showed abnormal Th17 generation. Transient NLRP3 silencing in nonmutant T cells or overexpression in mutant T cells normalized the Th profile. Interestingly, IL-17 blockade reduced Th17 skewing of human T cells in vitro and abrogated the severe allograft vasculopathy and abnormal Th17 generation observed in preclinical models in which P2X7R was genetically deleted. This P2X7R intracellular region mutation thus impaired the modulatory effects of P2X7R on NLRP3 expression and function in T cells and led to NLRP3 dysregulation and Th17 skewing, delineating a high-risk group of cardiac-transplanted patients who may benefit from personalized therapy.Funding Information
- American Heart Association (Grant-in-Aid)
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health (U01-AI063594, U01-AI063623)
This publication has 48 references indexed in Scilit:
- The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3Nature Communications, 2016
- The receptor NLRP3 is a transcriptional regulator of TH2 differentiationNature Immunology, 2015
- The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory responseNature Immunology, 2014
- The Link between the PDL1 Costimulatory Pathway and Th17 in Fetomaternal ToleranceThe Journal of Immunology, 2011
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7RNature Medicine, 2010
- The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant modelJCI Insight, 2008
- P2X receptors as cell-surface ATP sensors in health and diseaseNature, 2006
- A Thr357 to Ser Polymorphism in Homozygous and Compound Heterozygous Subjects Causes Absent or Reduced P2X7 Function and Impairs ATP-induced Mycobacterial Killing by MacrophagesOnline Journal of Public Health Informatics, 2006
- An Arg307 to Gln Polymorphism within the ATP-binding Site Causes Loss of Function of the Human P2X7 ReceptorOnline Journal of Public Health Informatics, 2004
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991